Today's Date: March 28, 2024
LambdaTest Launches The Phoenix Project, an Employee Resource Group for Women   •   ElementalTV and Spanglish Movies Partner to Accelerate US Hispanic Market Activations in CTV Advertising: 'Spanglish Audiences'   •   Guaranteed Rate Welcomes New Atlanta Branch Manager, Carlos Mata   •   Leading In-Home Care Franchise Looks to Expand in La Crosse   •   Eight new sustainability-themed experiences—exclusive to Yokohama—for convention participants   •   Boston Children’s Hospital and NRG Energy celebrate $1 million milestone, thanks to the Choose to Give program   •   The NRP Group and Housing Authority of the City of Austin Celebrate Grand Opening of The Markson, a 330-Unit Mixed-Income Commun   •   $122.5 Million Healthcare Transformation Grant Launches Center for Better Aging   •   The reopening of the Yokohama Museum of Art adds another innovative and distinctive venue for events in Yokohama   •   Colibri Group Announces Partnership with The University of Tulsa for Professional Licensure Program for Students in Real Estate,   •   /R E M I N D E R -- Travelling for Easter? The Canada Border Services Agency gives tips for a smooth trip/   •   Join Us as We Stand Together and March Against Hate in Dallas, Texas   •   iLearningEngines, Inc. to Add Michael Moe and Sir Ian Davis to its Board of Directors   •   BMO Recognized for Gender Equity by Report on Business' Women Lead Here List 2024   •   Yiwugo Embraces Surge in Demand for Chinese Trendy Products: Hanfu & Handcrafted Beads in Vogue   •   Jack Link’s® Unveils a Sweet Collaboration with Dr Pepper® That Brings Two Classic Tastes Together   •   G&A INSTITUTE ANNOUNCES 2024 PATHFINDER WEBINAR SERIES: Navigating the New Regulatory Environment for Corporate Sustainabili   •   Morningstar Publishes Fourth Annual Corporate Sustainability Report   •   Reveal Technology, Inc. Receives $3.2M Award With U.S. Marine Corps Warfighting Laboratory (MCWL)   •   Details of “SusHi Tech Tokyo 2024” Showcase Program Announced
Bookmark and Share

The World Stroke Organization Advises Public to be Vigilant for Symptoms of Rare Stroke Linked to Johnson & Johnson and Astr

The World Stroke Organization Advises Public to be Vigilant for Symptoms of Rare Stroke Linked to Johnson & Johnson and AstraZeneca COVID Vaccines

PR Newswire

GENEVA, April 15, 2021 /PRNewswire/ -- The World Stroke Organization is calling for increased awareness of the symptoms of a rare type of stroke that has been linked to a Johnson & Johnson and AstraZeneca COVID-19 vaccines. The call follows the suspension of administration of the Johnson & Johnson vaccine in the US and recent changes to clinical guidance on the use of the AstraZeneca in Europe, due to the rare occurrence of cerebral venous sinus thrombosis (CVST) in patients who have received these vaccines.

CVST is a type of blood clot that forms in the venous sinuses of your brain and can cause blood cells to break and leak into brain tissue. It is a rare disorder that currently accounts for 1-2% of stroke worldwide. CVST is more common in women, as it was in the reported cases following J&J and AstraZeneca vaccination.

While the population risks from COVID vaccination, are outweighed by the benefits of vaccination, including the reduced risk of COVID-related stroke, the World Stroke Organization (WSO) is calling on the public and healthcare professionals to be aware of the risk factors and symptoms of CVST and appropriate diagnosis of the disorder. It is vital that anyone with suspected CVST receives timely and appropriate neurological assessment and treatment to reduce the risk of severe disability and death.

Individuals who are predisposed to CVST include people with blood clotting disorders; women who are taking oral contraceptives, pregnant or post-partum; and people with pre-existing malignant disease.

The symptoms of CVST include headache, blurred vision, loss of control of movement in parts of the body, seizures, fainting, speech difficulties and confusion. Many patients present with nonspecific headaches, so any new headaches, or a change in the character of an existing headache, should not ignored where an individual has received the J&J or AstraZeneca vaccine.

Diagnosis of CVST requires specialist neurological examination of suspected patients. Brain imaging can be used to confirm the presence of a blood clot or hemorrhage, both of which can occur with CVST. Once a diagnosis has been made, treatment with a blood thinning medication is usually started.

WSO is monitoring emerging evidence and will provide further guidance as details about the CVST cases associated with COVID-19 vaccination emerge.

www.world-stroke.org

Logo - https://mma.prnewswire.com/media/1488968/World_Stroke_Organization_Logo.jpg

For more information, please contact the WSO Secretariat: admin@world-stroke.org.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/the-world-stroke-organization-advises-public-to-be-vigilant-for-symptoms-of-rare-stroke-linked-to-johnson--johnson-and-astrazeneca-covid-vaccines-301270080.html

SOURCE World Stroke Organization



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News